Improvements to Internal Controls over Financial Reporting and Governance Following Improper Accounting Practices
First written in FY2025. 8 of 10 entries say "Advanced", first in 2026-04-08. Latest entry: 2026-10-01.
1 other company's latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「As one year had passed since the designation as a Specially Cautioned Issue, the company submitted an “Internal Management System Confirmation Report” to the Tokyo Stock Exchange on 27 August 2026, as described in its notice dated the same day, “Notice Regarding the Development and Operation of the Internal Management System and Other Matters.” The report describes the status of improvements to the company’s internal management system and other matters.」
Regarding improvements to internal controls and governance following the inappropriate accounting, the company submitted an Internal Management System Confirmation Report one year after the designation as a Specially Cautioned Issue, moving into the exchange’s review stage. - FY2026AdvancedAnnual report
「Following the designation as a Specially Cautioned Issue, the company prepared an “Improvement Plan and Status Report” to address the deficiencies that led to the designation and establish internal management systems, and submitted it to the Tokyo Stock Exchange on 30 January 2026. The company is proceeding with improvement measures across the organisation, including corrective actions for the previously mentioned deficiencies in internal controls.」
Regarding improvement measures following the inappropriate accounting treatment, the company submitted an Improvement Plan and Status Report on 30 January 2026 and moved into the implementation phase for corrective actions across the organisation. However, the designation as a Specially Cautioned Issue remains in effect. - 2026-04-08AdvancedGeneral Meetings of Shareholders
「We take seriously the findings and recommendations in the investigation report of the Special Investigation Committee and our designation as a Specially Designated Securities, and will work to improve internal controls and governance under the strong commitment of top management.」
The business report explicitly stated that the improvement plan would be implemented with the involvement of top management to improve internal controls and governance. - FY2026-H1WorsenedAnnual report
「Although the company disclosed measures to prevent recurrence on 30 June 2025, the Tokyo Stock Exchange has determined that there remains a significant need to improve the company’s internal management systems and other matters. Accordingly, the company’s shares will be designated as a Specially Cautioned Issue.」
Even after the disclosure of measures to prevent recurrence, the Tokyo Stock Exchange continued to assess the need for significant improvements to the internal management systems and other matters, indicating that improving internal controls over financial reporting and governance remains an ongoing issue. - FY2025First statedAnnual report
「The company has taken the findings and recommendations in the Special Investigation Committee’s report seriously and will formulate effective measures to prevent recurrence and improve internal controls and governance under the strong commitment of top management.」
A package of improvement measures following the prior-year accounting treatment was presented, including establishing a recurrence-prevention committee headed by an external expert, continuing the activities of the Governance Committee, changing the CEO and CFO at IP Infusion, direct reporting to the company’s CFO, and strengthening second- and third-line controls at overseas locations.